Effect on Normal Vaginal Flora of Three Intravaginal Microbicidal Agents Potentially Active against Human Immunodeficiency Virus Type 1

The effect on normal vaginal flora of three intravaginal microbicides potentially active against human immunodeficiency virus type 1 was examined. Volunteers received dextrin sulfate (D2S), nonoxynol-9 (N-9), or docusate sodium in separate placebo-controlled studies. High vaginal swabs were obtained...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 177; no. 5; pp. 1386 - 1390
Main Authors: Rosenstein, Isobel J., Stafford, Michael K., Kitchen, Valerie S., Ward, Helen, Weber, Jonathan N., Taylor-Robinson, David
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-05-1998
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effect on normal vaginal flora of three intravaginal microbicides potentially active against human immunodeficiency virus type 1 was examined. Volunteers received dextrin sulfate (D2S), nonoxynol-9 (N-9), or docusate sodium in separate placebo-controlled studies. High vaginal swabs were obtained for bacterial culture before and after microbicide application. D2S did not affect the vaginal flora. However, lactobacilli decreased by ⩾102 cfu/mL in 9 (56%) of 16 women given N-9 and in 5 (63%) of 8 women given docusate sodium. Women using N-9 were also significantly more likely to become colonized abnormally (usually with aerobic gram-negative rods) than were those using placebo, as were women using docusate sodium. Women with reduced lactobacilli were less likely to regain normal flora than were those whose lactobacilli were unaffected. However, coliform colonization occurred whether lactobacilli produced H2O2 or not. Continuous use of N-9 could induce susceptibility to urinary and gynecological infection. It is essential that potential microbicides are examined for activity against normal vaginal flora.
Bibliography:istex:F16C8D7EC8973D602CE05BF67174A806F350AE29
ark:/67375/HXZ-H2WB6DWL-C
Presented in part: Medical Society for the Study of Venereal Diseases, London, 27 October 1995; International Conference on HIV Vaccines and Vaginal Microbicide Development, Bethesda, Maryland, 12–13 February 1996; 11th International Conference on AIDS, Vancouver, Canada, 7–12 July 1996 (abstract ThC 324); International Congress of Sexually Transmitted Diseases, Seville, Spain, 19–22 October 1997.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1086/517820